"10.1371_journal.pone.0060380","plos one","2013-04-08T00:00:00Z","Onyeka W Okonkwo; Ruchika Batwara; Ignacio Granja; John R Asplin; David S Goldfarb","Department of Medicine, New York Harbor VA Healthcare System and NYU School of Medicine, New York, New York, United States of America; Nephrology, Newark Beth Israel Medical Center, Newark, New Jersey, United States of America; Litholink Corp, Chicago, Illinois, United States of America; Nephrology Section, New York Harbor VA Healthcare System, and NYU Langone Medical Center, New York, New York, United States of America","Conceived and designed the experiments: OO RB JA DG. Performed the experiments: OO RB IG JA DG. Analyzed the data: JA RB DG. Contributed reagents/materials/analysis tools: JA IG. Wrote the paper: OO DG RB JA.","Ignacio Granja and John R. Asplin are employed by Litholink. John R. Asplin is a consultant to Oxthera Corp. David S. Goldfarb is a consultant for Takeda and Keryx and a speaker for CME Quintiles, Mission and owner, Ravine Group. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","04","Onyeka W Okonkwo","OWO",5,TRUE,4,5,3,4,TRUE,FALSE,FALSE,0,NA,FALSE
